Company: CERO
Filing Date: 2025-07-21
Form Type: S-1
Source: 0001213900-25-066152
Chunk: 2

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-07-21
Form: S-1
Chunk 2
---
 2025, by and between us and Keystone (the “New Keystone Purchase Agreement”). We have separately registered the resale pursuant to the Prior Registration Statements (as defined below) of 112,274 shares of Common Stock (the “Old Keystone Purchase Shares”) for aggregate proceeds of $7,509,103, consisting of (i) 100,584 shares of Common Stock that have been issued to Keystone, as of June 30, 2025, pursuant to a Common Stock Purchase Agreement, dated as of November 8, 2024, by and between us and Keystone (the “November 2024 Keystone Purchase Agreement,”) and (ii) 11,690 shares of Common Stock that have been issued to Keystone pursuant to a Common Stock Purchase Agreement, dated as of February 14, 2024, by and between us and Keystone (the “February 2024 Keystone Purchase Agreement,” together with the New Keystone Purchase Agreement and the November 2024 Keystone Purchase Agreement, the “Keystone Purchase Agreements”), as consideration for it establishing an equity line of credit (the “Keystone Equity Financing”). We previously filed a registration statement on Form S-1 (File No. 333-278603), which was declared effective by the Securities and Exchange Commission (the “SEC”) on May 1, 2024, and remains in effect, with respect to up to (i) 12,500 Keystone Purchase Shares (as defined below) and (ii) 310 Keystone Commitment Shares (as defined below), and a registration statement on Form S-1 (File No. 333-283492), which was declared effective by the SEC on December 5, 2024, and remains in effect, with respect to (i) 104,318 Keystone Purchase Shares and (ii) 682 Keystone Commitment Shares (collectively, the “Prior Registration Statements”). The actual number of shares of our Common Stock issuable will vary depending on the then-current market price of shares of our Common Stock sold to Keystone under the Keystone Purchase Agreements, but will not exceed the number set forth in the preceding sentences unless we file an additional registration statement under the Securities Act of 1933, as amended (the “Securities Act”), with the SEC. See “ The Committed Equity Financing” for a description of the Keystone Purchase Agreements and “ Selling Securityholder” for additional information regarding Keystone. We are not selling any securities under this prospectus and will not receive any of the proceeds from the sale